Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.83)
# 3,850
Out of 4,898 analysts
314
Total ratings
24.36%
Success rate
-28.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
INKT MiNK Therapeutics | Downgrades: Neutral | $35 | $29.29 | +19.49% | 13 | Jul 15, 2025 | |
RAPT RAPT Therapeutics | Maintains: Buy | $6 → $27 | $10.25 | +163.41% | 2 | Jul 10, 2025 | |
JSPR Jasper Therapeutics | Maintains: Buy | $40 → $20 | $3.33 | +500.60% | 10 | Jul 7, 2025 | |
NXTC NextCure | Reiterates: Buy | $36 | $4.80 | +649.98% | 9 | Jul 1, 2025 | |
FEMY Femasys | Reiterates: Buy | $12 | $0.93 | +1,190.32% | 24 | Jun 25, 2025 | |
ACLX Arcellx | Reiterates: Buy | $115 | $67.82 | +69.57% | 13 | Jun 16, 2025 | |
ARTV Artiva Biotherapeutics | Assumes: Buy | $12 | $2.21 | +442.99% | 1 | Jun 11, 2025 | |
AGEN Agenus | Upgrades: Buy | $25 | $6.20 | +303.23% | 18 | Jun 4, 2025 | |
ANAB AnaptysBio | Upgrades: Buy | $22 → $38 | $26.33 | +44.32% | 10 | Jun 4, 2025 | |
SABS SAB Biotherapeutics | Assumes: Buy | $10 | $2.50 | +300.00% | 1 | May 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.72 | +535.59% | 20 | Apr 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $4.22 | +160.66% | 11 | Apr 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $1.91 | +1,575.39% | 14 | Apr 22, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $8.79 | +3,085.44% | 17 | Apr 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $16.99 | +111.89% | 1 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.45 | +451.72% | 6 | Apr 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.82 | +559.34% | 13 | Apr 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.23 | +828.82% | 7 | Mar 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.24 | +1,432.26% | 12 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.81 | +894.48% | 15 | Mar 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.49 | +2,756.56% | 12 | Mar 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.93 | +651.80% | 14 | Mar 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.74 | +572.86% | 11 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.28 | - | 5 | Mar 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $9.13 | +162.87% | 5 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $58 | $39.06 | +48.49% | 1 | Feb 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.70 | +2,465.20% | 1 | Feb 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.95 | - | 15 | Jan 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $16.94 | +124.32% | 18 | Jan 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $2.54 | +1,199.26% | 14 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.68 | - | 1 | Apr 25, 2024 |
MiNK Therapeutics
Jul 15, 2025
Downgrades: Neutral
Price Target: $35
Current: $29.29
Upside: +19.49%
RAPT Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $6 → $27
Current: $10.25
Upside: +163.41%
Jasper Therapeutics
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $3.33
Upside: +500.60%
NextCure
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $4.80
Upside: +649.98%
Femasys
Jun 25, 2025
Reiterates: Buy
Price Target: $12
Current: $0.93
Upside: +1,190.32%
Arcellx
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $67.82
Upside: +69.57%
Artiva Biotherapeutics
Jun 11, 2025
Assumes: Buy
Price Target: $12
Current: $2.21
Upside: +442.99%
Agenus
Jun 4, 2025
Upgrades: Buy
Price Target: $25
Current: $6.20
Upside: +303.23%
AnaptysBio
Jun 4, 2025
Upgrades: Buy
Price Target: $22 → $38
Current: $26.33
Upside: +44.32%
SAB Biotherapeutics
May 14, 2025
Assumes: Buy
Price Target: $10
Current: $2.50
Upside: +300.00%
Apr 28, 2025
Reiterates: Buy
Price Target: $30
Current: $4.72
Upside: +535.59%
Apr 24, 2025
Reiterates: Buy
Price Target: $11
Current: $4.22
Upside: +160.66%
Apr 22, 2025
Reiterates: Buy
Price Target: $32
Current: $1.91
Upside: +1,575.39%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $8.79
Upside: +3,085.44%
Apr 9, 2025
Initiates: Buy
Price Target: $36
Current: $16.99
Upside: +111.89%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $1.45
Upside: +451.72%
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $1.82
Upside: +559.34%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $3.23
Upside: +828.82%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.24
Upside: +1,432.26%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $1.81
Upside: +894.48%
Mar 26, 2025
Reiterates: Buy
Price Target: $14
Current: $0.49
Upside: +2,756.56%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.93
Upside: +651.80%
Mar 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.74
Upside: +572.86%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.28
Upside: -
Feb 26, 2025
Upgrades: Buy
Price Target: $24
Current: $9.13
Upside: +162.87%
Feb 24, 2025
Reiterates: Buy
Price Target: $58
Current: $39.06
Upside: +48.49%
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $0.70
Upside: +2,465.20%
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.95
Upside: -
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $16.94
Upside: +124.32%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $2.54
Upside: +1,199.26%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.68
Upside: -